Gossett R E, Frolov A A, Roths J B, Behnke W D, Kier A B, Schroeder F
Department of Pathobiology, Texas A&M University, TVMC, College Station 77843-4466, USA.
Lipids. 1996 Sep;31(9):895-918. doi: 10.1007/BF02522684.
The physiological role of long-chain fatty acyl-CoA is thought to be primarily in intermediary metabolism of fatty acids. However, recent data show that nM to microM levels of these lipophilic molecules are potent regulators of cell functions in vitro. Although long-chain fatty acyl-CoA are present at several hundred microM concentration in the cell, very little long-chain fatty acyl-CoA actually exists as free or unbound molecules, but rather is bound with high affinity to membrane lipids and/or proteins. Recently, there is growing awareness that cytosol contains nonenzymatic proteins also capable of binding long-chain fatty acyl-CoA with high affinity. Although the identity of the cytosolic long-chain fatty acyl-CoA binding protein(s) has been the subject of some controversy, there is growing evidence that several diverse nonenzymatic cytosolic proteins will bind long-chain fatty acyl-CoA. Not only does acyl-CoA binding protein specifically bind medium and long-chain fatty acyl-CoA (LCFA-CoA), but ubiquitous proteins with multiple ligand specificities such as the fatty acid binding proteins and sterol carrier protein-2 also bind LCFA-CoA with high affinity. The potential of these acyl-CoA binding proteins to influence the level of free LCFA-CoA and thereby the amount of LCFA-CoA bound to regulatory sites in proteins and enzymes is only now being examined in detail. The purpose of this article is to explore the identity, nature, function, and pathobiology of these fascinating newly discovered long-chain fatty acyl-CoA binding proteins. The relative contributions of these three different protein families to LCFA-CoA utilization and/or regulation of cellular activities are the focus of new directions in this field.
长链脂肪酰辅酶A的生理作用被认为主要在于脂肪酸的中间代谢。然而,最近的数据表明,这些亲脂性分子在纳摩尔到微摩尔水平时是体外细胞功能的有效调节剂。尽管长链脂肪酰辅酶A在细胞中的浓度为数百微摩尔,但实际上只有极少部分长链脂肪酰辅酶A以游离或未结合的分子形式存在,而是以高亲和力与膜脂和/或蛋白质结合。最近,人们越来越意识到细胞质中含有非酶蛋白,它们也能够以高亲和力结合长链脂肪酰辅酶A。尽管细胞质长链脂肪酰辅酶A结合蛋白的身份一直存在一些争议,但越来越多的证据表明,几种不同的非酶细胞质蛋白会结合长链脂肪酰辅酶A。酰基辅酶A结合蛋白不仅能特异性结合中链和长链脂肪酰辅酶A(LCFA-CoA),而且具有多种配体特异性的普遍存在的蛋白质,如脂肪酸结合蛋白和固醇载体蛋白-2,也能以高亲和力结合LCFA-CoA。这些酰基辅酶A结合蛋白影响游离LCFA-CoA水平,进而影响与蛋白质和酶中调节位点结合的LCFA-CoA量的潜力,目前才开始详细研究。本文的目的是探讨这些新发现的迷人的长链脂肪酰辅酶A结合蛋白的身份、性质、功能和病理生物学。这三个不同蛋白质家族对LCFA-CoA利用和/或细胞活动调节的相对贡献是该领域新方向的重点。